Search research articles
Contact Us
Filters
Showing results (41-50 of 82) with videos related to
Page
of 9
Sort By:
Frontiers in Immunology
|
April 21, 2025
Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series
Regina Berkovich, Jonathan Calkwood, Heidi Crayton, et al.
Therapeutic Advances in Neurological Disorders
|
July 21, 2021
The impact of the COVID-19 pandemic on hospitalizations and plasmapheresis therapy in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide analysis from Germany
Daniel Richter, Simon Faissner, Dirk Bartig, et al.
Brain and Behavior
|
February 28, 2015
"Liberation treatment" for chronic cerebrospinal venous insufficiency in multiple sclerosis: the truth will set you free
Georgios Tsivgoulis, Simon Faissner, Konstantinos Voumvourakis, et al.
Scientific Reports
|
August 1, 2024
Siponimod treatment response shows partial BDNF dependency in multiple sclerosis models
Hasan Hüseyin Hendek, Alina Blusch, Neele Heitmann, et al.
Journal of Neurology
|
May 13, 2022
Hypoechogenicity of brainstem raphe in long-COVID syndrome-less common but independently associated with depressive symptoms: a cross-sectional study
Daniel Richter, Hannah Schulze, Jeyanthan Charles James, et al.
Journal of Neuroinflammation
|
March 13, 2017
Teriflunomide and monomethylfumarate target HIV-induced neuroinflammation and neurotoxicity
Björn Ambrosius, Simon Faissner, Kirsten Guse, et al.
Scientific Reports
|
January 11, 2025
Neurological post-COVID syndrome is associated with substantial impairment of verbal short-term and working memory
Jeyanthan Charles James, Hannah Schulze, Nadine Siems, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 17, 2024
Successful use of anti-CD19 CAR T cells in severe treatment-refractory stiff-person syndrome
Simon Faissner, Jeremias Motte, Melissa Sgodzai, et al.
Frontiers in Neurology
|
October 31, 2022
Cross-sectional analysis of clinical aspects in patients with long-COVID and post-COVID syndrome
Hannah Schulze, Jeyanthan Charles James, Nadine Trampe, et al.
CNS Neuroscience & Therapeutics
|
October 15, 2016
Immunotherapy Improves Cognitive Function in Secondary Progressive Multiple Sclerosis
Markus Kinner, Robert Hoepner, Peter Klotz, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 82) with videos related to
Sort By:
Page
of 9
Frontiers in Immunology
|
April 21, 2025
Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series
Regina Berkovich, Jonathan Calkwood, Heidi Crayton, et al.
Therapeutic Advances in Neurological Disorders
|
July 21, 2021
The impact of the COVID-19 pandemic on hospitalizations and plasmapheresis therapy in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide analysis from Germany
Daniel Richter, Simon Faissner, Dirk Bartig, et al.
Brain and Behavior
|
February 28, 2015
"Liberation treatment" for chronic cerebrospinal venous insufficiency in multiple sclerosis: the truth will set you free
Georgios Tsivgoulis, Simon Faissner, Konstantinos Voumvourakis, et al.
Scientific Reports
|
August 1, 2024
Siponimod treatment response shows partial BDNF dependency in multiple sclerosis models
Hasan Hüseyin Hendek, Alina Blusch, Neele Heitmann, et al.
Journal of Neurology
|
May 13, 2022
Hypoechogenicity of brainstem raphe in long-COVID syndrome-less common but independently associated with depressive symptoms: a cross-sectional study
Daniel Richter, Hannah Schulze, Jeyanthan Charles James, et al.
Journal of Neuroinflammation
|
March 13, 2017
Teriflunomide and monomethylfumarate target HIV-induced neuroinflammation and neurotoxicity
Björn Ambrosius, Simon Faissner, Kirsten Guse, et al.
Scientific Reports
|
January 11, 2025
Neurological post-COVID syndrome is associated with substantial impairment of verbal short-term and working memory
Jeyanthan Charles James, Hannah Schulze, Nadine Siems, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 17, 2024
Successful use of anti-CD19 CAR T cells in severe treatment-refractory stiff-person syndrome
Simon Faissner, Jeremias Motte, Melissa Sgodzai, et al.
Frontiers in Neurology
|
October 31, 2022
Cross-sectional analysis of clinical aspects in patients with long-COVID and post-COVID syndrome
Hannah Schulze, Jeyanthan Charles James, Nadine Trampe, et al.
CNS Neuroscience & Therapeutics
|
October 15, 2016
Immunotherapy Improves Cognitive Function in Secondary Progressive Multiple Sclerosis
Markus Kinner, Robert Hoepner, Peter Klotz, et al.
Page
of 9